Skip to content

Incidences, Causes, and Outcomes of Febrile Illness in Rural South and Southeast Asia

Determining the Incidence, Causes and Outcomes of Rural Febrile Illness (RFI) in South and Southeast Asia, as Part of the South and Southeast Asian Community-based Trials Network (SEACTN). Work Package A (WP-A).

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04478578
Acronym
SEACTN-WP-A
Enrollment
100000
Registered
2020-07-20
Start date
2021-08-04
Completion date
2024-12-30
Last updated
2024-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Febrile Illness

Keywords

Febrile Illness, Incidence, Causes, Outcomes

Brief summary

The study will collect information to understand the causes and outcomes of febrile illness in rural areas in countries across South and Southeast Asia ( including Cambodia, Laos, Myanmar and Bangladesh). The findings will be used to identify new tests and treatments that can improve the management of febrile patients in the future. This study is funded by the UK Wellcome Trust. The grant reference number is 215604/Z/19/Z

Detailed description

This study aims to better understand and quantify the burden of febrile illness, the aetiological causes and the manner in which it affects the people living in rural areas in South and Southeast Asia, all on a scale which has not been attempted before. The SEACTN RFI project will collect information to help better understand and predict these outcomes based on a multitude of factors, which will form the basis for interventions within the network in the future. Determining the incidence, causes and outcomes of febrile illness in these settings will be done through two work packages. The first of these, Work Package A (WP-A), the subject of this study, will be carried out at the community level, primarily by engaging village health worker (VHWs) and low-level Health Centres (HCs) which serve the communities to recruit patients presenting with a febrile illness. These patients will be assessed for presenting symptoms and followed up for clinical outcomes. Collection of specimen for diagnostic investigations in these settings is challenging. Currently, mRDTs are conducted by VHWs and HCs in these networks, therefore by using the same process, but also applying blood to filter paper and allowing it to dry (DBS), investigators will test for certain other pathogens, which will increase the aetiological yield.

Interventions

None listed

Sponsors

Medical Action Myanmar
CollaboratorOTHER
Shoklo Malaria Research Unit
CollaboratorOTHER
Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit
CollaboratorOTHER
Building Resources Across Communities (BRAC), Bangladesh
CollaboratorUNKNOWN
Mahidol Oxford Tropical Medicine Research Unit
CollaboratorOTHER
Action for Health Development (AHEAD)
CollaboratorUNKNOWN
University of Oxford
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Documented fever (≥ 37.5°C axillary), hypothermia (\< 35.5°C) and/or history of fever in the last 24 hours. * Willingness and ability to comply with study protocol for the study duration. * Written informed consent given to participate in the trial.

Exclusion criteria

* Currently enrolled in the study * Accident or trauma is the cause for presentation * Presentation ≤ 3 days after routine immunisations

Design outcomes

Primary

MeasureTime frameDescription
Local incidence of febrile illnessFrom Months 0 to 24The incidence per year that an individual seeks care for a febrile illness with the village health workers or local health facility, at the village level.
Overall incidence of febrile illnessFrom Months 0 to 24The incidence per year that an individual seeks care for a febrile illness with the village health workers or local health facility, at the regional level. These estimates will later be triangulated with and extrapolated from using health seeking behavior surveys for an estimate of the total incidence of febrile illness.
MortalityWithin approximately 1 month of first presentation to the village health worker or health facilityCase fatality rates in febrile illness
MorbidityOver 1 month after first presentationDuration of illness in patients presenting with a fever to the village health worker or health facility.

Secondary

MeasureTime frameDescription
Prevalence of pathogens in febrile patientsSamples collected over approximately 24 monthsPathogens will be detected in patients presenting over a 24 month period using point of care tests and diagnostic assays on acute and convalescent dried blood spots.
The correlation between host biomarker concentrations, aetiological diagnoses and clinical outcomes.Samples collected over approximately 24 monthsThe area under the curve, sensitivity and specificity of host biomarkers to identify bacterial infections and to predict severe outcomes.

Countries

Bangladesh, Burma, Cambodia, Laos, Thailand

Contacts

Primary ContactYoel Lubell, Prof.
yoel@tropmedres.ac+66-857201350

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026